Aurora Cannabis Inc (ACB)

NASDAQHealthcare

$3.48
+$0.04 (+1.5%)
Market closed

April 9, 2026 at 20:00 UTC

Interactive Chart

ACB
1H
3H
6H
12H
1D
1W
1M
3M
6M
1Y
2Y
5Y
All

21:41:04 UTC

About Aurora Cannabis Inc

Name
Aurora Cannabis Inc
CEO
Miguel Martin
Industry
Healthcare
Year Founded
2006
Employees
1,073

Aurora Cannabis Inc is a cannabis company that cultivates, processes, and distributes regulated products for adult-use and medical channels under strict quality systems. The business is built around controlled growing environments, standardized post-harvest methods, and documentation that satisfies varying provincial and international rules. Pharmacies, wholesalers, and licensed retailers rely on consistent specifications and clear labeling, while physicians and patients expect predictable formats and guidance that fits routine care. Aurora concentrates on scale that can be audited, rather than one-off launches, so supply and compliance move in step. Export pathways are developed in line with local authorities, reflecting a view that market access and stewardship go together. Within the consumer staples and healthcare ecosystem, the company presents cannabis as a category managed with the same patience and record-keeping that regulated products demand.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 8 Buy, 9 Hold, 6 Sell
Buy8
Hold9
Sell6

Fundamentals & Financials

Revenue (TTM)
$363.2M
Net Income (TTM)
-$42.5M
EPS (TTM)
-$1.69
ROA (TTM)
-5.49%
Current Ratio
3.06
Dividend Yield
-

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ4 2025
Revenue$94,191K
Cost of Sales$47,571K
Gross Profit$46,620K
Operating Income$4,806K
Net Income$1,820K
EPS$0.032

Technical Indicators

Aurora Cannabis Inc's Technical Indicators Summary

At 3.43 the technical picture for ACB is mixed, with short-term averages sitting above the price while longer-term moving averages remain clearly higher, producing a neutral posture. Momentum readings are tepid and RSI sits near the midpoint, while OBV shows accumulation even as ADX indicates only weak trend strength and volatility is moderate at roughly a 4.5% ATR. Classic and Fibonacci pivots are close to the current price, offering nearby reference support. Technical takeaway: Neutral — short-term support meets longer-term resistance, with limited trend conviction.

Buy
8 signals
Neutral
9 signals
Sell
6 signals
Overall: Neutral39% Neutral signals
IndicatorValue
RSI (14)
49.20
Stochastic %K (14, 3, 3)
70.64
CCI (20)
58.15
WPR (14)
-28.00
Momentum (10)
0.11
MFI
60.26
MACD Level (12, 26)
-0.07
Bollinger Bands
$3.14 - $3.62
ATR (14)
$0.16 (4.52%)
ADX (14)
17.65
OBV
11,239,132
Classic Pivot Point
$3.38
Fibonacci Pivot Point
$3.38
Simple Moving Averages
$3.33 - $4.49(5 indicators)
Exponential Moving Averages
$3.37 - $4.34(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

By the close, ACB held onto a small 1.46% gain versus yesterday, finishing at 3.48. End-of-day, the peer group was roughly unchanged (-0.24%), limiting broader influence on ACB. ACB extended a modest gain as its peers stayed flat, implying stock-specific momentum rather than sector moves.

Price Change

from $3.48 close

+$0.01

Trading Volume

Below avg (687.3K)

535.6K

vs S&P 500 Today

Underperforming Market

-0.60%

52-Week Position

Lower range

11.4%

Updated: April 9, 2026 at 20:01 UTC

Quote Summary

OpenPrevious Close
$3.53$3.46
Day Range52 Week Range
$3.4 - $3.57$3.07 - $6.67
VolumeAvg. Volume
654.2K868.5K
Market CapP/E Ratio
$194.5M-31.2